ONWARD Medical: ARC-BCI is once again in the spotlight of the FDA perks!
ARC-BCI is once again in the spotlight of the FDA perks! Following the Breakthrough Device Designation (BDD) that was awarded by the FDA about two weeks ago, ONWARD announced this morning that ARC-BCI has entered into the Total Product Life Cycle Advisory Program (TAP) from the FDA, being one the f
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.